Literature DB >> 18473759

Metabolic syndrome--risk factors for atherosclerosis and diabetes.

Marko Mihic1, Pankaj Modi.   

Abstract

OBJECTIVE: To evaluate the lipoprotein profiles, triglycerides and glycemia along with the abdominal fat to explore the risk factors associated with non-diabetic state to IGF, IGT and Type-2 diabetes in Canadian population.
METHODS: We examined 780 subjects using the ADA and WHO criteria to classify them into groups based on (1) normal glucose tolerance with FBS <6.0 and 2hBS <7.0 mmol/l), (2) IFG; FPG > or =6.1 mmol/l but 2hBS >7.8-11.1 mmol/l; (3) combined IFG/IGT (FPG > or =7.0 mmol/l and 2hBS >11.1 mmol/l). We compared the three groups for glycemia, insulin secretion and insulin sensitivity based on their WHR, abdominal and visceral fat measurements.
RESULTS: The subjects with higher 2 hrs glucose levels 5.2 for NGT vs. 9.1 for IGT and 13.4 mmol/l for NIDDM, p<0.001, apo C-III level (12.8 (DM) vs. 8.9 mg/dl (normal), p<0.001), waist to hip ratio (0.91 (IGT) vs. 0.89 (Normal), p<0.01) and abdominal fat and were found to be highly insulin resistant.
CONCLUSIONS: The higher apolipoproteins levels, BMI and abdominal and visceral fat accompanied by poor glycemia were shown to be associated strongly with the metabolic abnormalities. These factors led to the worsening of insulin secretory dysfunction and insulin resistance and were strong predictors of diabetes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18473759     DOI: 10.2174/157339908784220750

Source DB:  PubMed          Journal:  Curr Diabetes Rev        ISSN: 1573-3998


  6 in total

1.  Discrimination of ischemic and hemorrhagic strokes using a multiplexed, mass spectrometry-based assay for serum apolipoproteins coupled to multi-marker ROC algorithm.

Authors:  Mary F Lopez; David A Sarracino; Amol Prakash; Michael Athanas; Bryan Krastins; Taha Rezai; Jennifer N Sutton; Scott Peterman; Oksana Gvozdyak; Sherry Chou; Eng Lo; Ferdinand Buonanno; MingMing Ning
Journal:  Proteomics Clin Appl       Date:  2012-04       Impact factor: 3.494

2.  Lipoproteins and lipoprotein metabolism in periodontal disease.

Authors:  Rachel Griffiths; Suzanne Barbour
Journal:  Clin Lipidol       Date:  2010-06

3.  Pancreatic magnetic resonance imaging after manganese injection distinguishes type 2 diabetic and normoglycemic patients.

Authors:  Diomidis Botsikas; Sylvain Terraz; Laurent Vinet; Smaragda Lamprianou; Christoph D Becker; Domenico Bosco; Paolo Meda; Xavier Montet
Journal:  Islets       Date:  2012-05-01       Impact factor: 2.694

4.  Influence of islet function on typing and prognosis of new-onset diabetes after intensive insulin therapy.

Authors:  Hui Fan; QingRong Pan; Pengrui Zhang; Jia Liu; Yuan Xu; Xinchun Yang
Journal:  Med Sci Monit       Date:  2013-09-23

5.  Low-density lipoprotein electronegativity is a novel cardiometabolic risk factor.

Authors:  Jing-Fang Hsu; Tzu-Chieh Chou; Jonathan Lu; Shu-Hua Chen; Fang-Yu Chen; Ching-Chu Chen; Jeffrey L Chen; MacArthur Elayda; Christie M Ballantyne; Steven Shayani; Chu-Huang Chen
Journal:  PLoS One       Date:  2014-09-09       Impact factor: 3.240

6.  Sex -Specific Differences in the Association Between Metabolic Syndrome and Carotid Intima-Media Thickness Among a Low-Income Population in China: A Cross-Sectional Study.

Authors:  Liming Fan; Qiaoxia Yang; Xin Zhang; Qiuxing Lin; Dandan Guo; Jie Liu; Jun Tu; Jinghua Wang; Yan Li; Xianjia Ning
Journal:  Diabetes Metab Syndr Obes       Date:  2021-07-15       Impact factor: 3.168

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.